{
    "title": "Avandia legal bill drags GSK into red",
    "url": "https://www.dailymail.co.uk/money/markets/article-1711970/Avandia-legal-bill-drags-GSK-into-red.html",
    "date": "2011-02-03",
    "keywords": [
        "gsk",
        "year",
        "drug",
        "uk",
        "loss",
        "quarter",
        "charge",
        "share",
        "profit",
        "companys",
        "patent",
        "site",
        "fund",
        "bill",
        "money",
        "view",
        "glaxosmithkline",
        "giant",
        "market",
        "europe",
        "risk",
        "heart",
        "avandia",
        "valtrex",
        "competition",
        "presence",
        "dependence",
        "company",
        "lesser",
        "consumer",
        "blockbuster",
        "sensodyne",
        "trading",
        "today",
        "executive",
        "business",
        "model",
        "restructuring",
        "approach",
        "growth",
        "product",
        "pipeline",
        "potential",
        "cash",
        "generation",
        "doubt",
        "scale",
        "provisioning",
        "unpredictability",
        "litigation",
        "exposure",
        "witty",
        "kent",
        "week",
        "research",
        "development",
        "operation",
        "interest",
        "lot",
        "moment",
        "something",
        "capital",
        "staff",
        "sandwich",
        "chancellor",
        "george",
        "osborne",
        "box",
        "reduction",
        "corporation",
        "tax",
        "property",
        "investment",
        "announcement",
        "manufacturing",
        "effect"
    ],
    "category": [
        "money",
        "markets"
    ]
}